Loss of NF2/Merlin expression in advanced sporadic colorectal cancer.
- Published in:
- Cellular Oncology (2211-3428), 2014, v. 37, n. 1, p. 69, doi. 10.1007/s13402-013-0164-2
- By:
- Publication type:
- Article
Works matching IS 22113428 AND DT 2014 AND VI 37 AND IP 1
Results: 7
1
2
Genetic gains and losses in oral squamous cell carcinoma: impact on clinical management.
- Published in:
- Cellular Oncology (2211-3428), 2014, v. 37, n. 1, p. 29, doi. 10.1007/s13402-013-0161-5
- By:
- Publication type:
- Article
3
A combination of paclitaxel and siRNA-mediated silencing of Stathmin inhibits growth and promotes apoptosis of nasopharyngeal carcinoma cells.
- Published in:
- Cellular Oncology (2211-3428), 2014, v. 37, n. 1, p. 53, doi. 10.1007/s13402-013-0163-3
- By:
- Publication type:
- Article
4
Thymidylate synthase expression and p21/p53 phenotype of colon cancers identify patients who may benefit from 5-fluorouracil based therapy.
- Published in:
- Cellular Oncology (2211-3428), 2014, v. 37, n. 1, p. 17, doi. 10.1007/s13402-013-0159-z
- By:
- Publication type:
- Article
5
High-level copy number gains of established and potential drug target genes in gastric cancer as a lead for treatment development and selection.
- Published in:
- Cellular Oncology (2211-3428), 2014, v. 37, n. 1, p. 41, doi. 10.1007/s13402-013-0162-4
- By:
- Publication type:
- Article
6
Etiology of familial breast cancer with undetected BRCA1 and BRCA2 mutations: clinical implications.
- Published in:
- Cellular Oncology (2211-3428), 2014, v. 37, n. 1, p. 1, doi. 10.1007/s13402-013-0158-0
- By:
- Publication type:
- Article
7
Clinical application of circulating tumor cells in breast cancer.
- Published in:
- Cellular Oncology (2211-3428), 2014, v. 37, n. 1, p. 9, doi. 10.1007/s13402-013-0160-6
- By:
- Publication type:
- Article